Clinical Validation of a Machine-learning–derived Signature Predictive of Outcomes from First-line Oxaliplatin-based Chemotherapy in Advanced Colorectal Cancer-Reference-Cited by-同舟云学术

Clinical Validation of a Machine-learning–derived Signature Predictive of Outcomes from First-line Oxaliplatin-based Chemotherapy in Advanced Colorectal Cancer

Published:2020-12-08 Issue:4 Volume:27 Page:1174-1183
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Abraham Jim P.,Magee Daniel,Cremolini Chiara,Antoniotti Carlotta,Halbert David D.,Xiu Joanne,Stafford Phillip,Berry Donald A.,Oberley Matthew J.^ORCID,Shields Anthony F.^ORCID,Marshall John L.^ORCID,Salem Mohamed E.,Falcone Alfredo^ORCID,Grothey Axel,Hall Michael J.,Venook Alan P.^ORCID,Lenz Heinz-Josef^ORCID,Helmstetter Anthony,Korn W. Michael^ORCID,Spetzler David B.

Funder

Caris Life Sciences

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sample Size Estimation Using a Partially Clustered Frailty Model for Biomarker‐Strategy Designs With Multiple Treatments;Pharmaceutical Statistics;2024-07-16

2. Colorectal cancer;The Lancet;2024-07

3. Possibilities and prospects of artificial intelligence in the treatment of colorectal cancer (review);Koloproktologia;2024-06-21

4. Robust and consistent biomarker candidates identification by a machine learning approach applied to pancreatic ductal adenocarcinoma metastasis;BMC Medical Informatics and Decision Making;2024-06-20

5. Molecular Profiling and the Impact of Treatment on Outcomes in Adenoid Cystic Carcinoma Type I and II;Clinical Cancer Research;2024-02-28